Clinical trial
Safety and Feasibility of Transition to Anti-thrombotic Monotherapy With the HeartMate 3 LVAS: A Multicenter Prospective Controlled Study
NCT03781258 is registered in ClinicalTrials.gov with Institute for Clinical and Experimental Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Feasibility of Transition to Anti-thrombotic Monotherapy With the HeartMate 3 LVAS: A Multicenter Prospective Controlled Study
- Lead sponsor
- Institute for Clinical and Experimental Medicine
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 23, 2018
- Completion date
- December 31, 2021
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.